by Jordana Choucair | Aug 8, 2022 | Public Health/Prevention
The U.S. Department of Health and Human Services Department is considering extending the COVID-19 public health emergency (PHE) once again. According to people familiar with the matter, HHS would potentially extend the declaration into early 2023 — pushing the U.S....
by Jordana Choucair | Aug 5, 2022 | D.C. News
The Biden administration declared monkeypox a public health emergency (PHE) in an effort to expedite the approval process for new treatments and provide more flexibility for federal agencies to respond to the outbreak. The announcement comes amid intense pressure from...
by Jordana Choucair | Aug 5, 2022 | D.C. News
Senator Kyrsten Sinema announced Thursday that she agreed to advance a modified version of the Democrats’ climate and tax bill. Majority Leader Chuck Schumer said he is teeing up a Saturday afternoon vote on a motion to proceed with the party’s reconciliation...
by Jordana Choucair | Aug 5, 2022 | D.C. News
The Congressional Budget Office (CBO) released a report projecting that Democrats’ climate and tax bill could cut the deficit by $101.5 billion over 10 years. The CBO also indicated that the party-line drug pricing legislation will likely cause manufacturers to...
by Jordana Choucair | Aug 5, 2022 | Life Sciences
PhRMA and its 31 board members sent a letter to every member of Congress yesterday imploring them to vote against Democrats’ reconciliation package. PhRMA CEO Steve Ubl said in an interview that lawmakers “who vote for this bill will not get a free...
by Jordana Choucair | Aug 5, 2022 | Life Sciences
Amgen Inc. secured a deal to buy ChemoCentryx Inc. for $3.7 billion, giving the biotech company access to the potential blockbuster drug Tavneos. The drug is used to treat patients with a rare type of blood vessel inflammation that generated $5.4 million in sales in...
Recent Comments